drugset / Trial / NCT04737603

Feasibility of Pediatric Emergency Department-Initiated Treatment for Adolescents With Opioid Use Disorder

NCT04737603

NaSingle-groupOpen-labelTreatment

Summary

ED-initiated buprenorphine with brief intervention and facilitated referral to treatment has been shown to be highly successful in increasing treatment engagement rates and reducing opioid use among adults. It is unknown whether this intervention is similarly effective for adolescents with OUD. To rigorously examine this important clinical research question, it is first necessary to optimize this intervention for the adolescent population. In this R34 proposal, we will use the Assessment-Decision-Administration-Production-Topic Experts-Integration-Training-Testing (ADAPT-ITT) framework-a systematic method for intervention adaptation- to adapt (Aim 1) and test the feasibility (Aim 2) of a treatment strategy for adolescents that has been shown to effectively link adults with OUD to ongoing addiction treatment.

Timeline

Start
2025-07-30
Primary completion
2025-07-30
Completion
2025-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified 12 mg Other
Subject Buprenorphine Other / unclassified 16 mg Other
Subject Naloxone Small molecule

Indications